Mauna Kea Technologies Welcomes Benoit Chardon as Senior Advisor to Scale its Irritable Bowel Syndrome and Food Intolerance Business

PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced that it has appointed Benoit Chardon as a senior advisor to scale its business where Cellvizio is now used to accurately diagnose food intolerance in patients suffering from Irritable Bowel Syndrome (IBS). Mr. Chardon is a recognized marketing and commercialization